HSBC Starts Actinium Pharma (ATNM) at Buy
Tweet Send to a Friend
HSBC analyst Morten Herholdt initiates coverage on Actinium Pharma (NYSE: ATNM) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




